DR. REDDY’S LABORATORIES
Dr. Reddy’s Laboratories is an integrated pharmaceutical company. The Company operates in three segments: Global Generics segment, which includes its prescription and over-the-counter (OTC) drug products business; Pharmaceutical Services and Active Ingredients (PSAI) segment, which consists of its active pharmaceutical ingredients (API) business and custom pharmaceutical services (CPS) business, and Proprietary Products segment, which consists of DRL’s new chemical entities (NCEs) business, its Differentiated Formulations business and its dermatology focused specialty business operated through Promius Pharma.
DR. REDDY’S LABORATORIES
Industry:
Biotechnology Health Care Medical
Founded:
1984-02-24
Address:
Hyderabad, Andhra Pradesh, India
Country:
India
Website Url:
http://www.drreddys.com
Total Employee:
10001+
Status:
Active
Contact:
+91 40 2373 1946
Email Addresses:
[email protected]
Total Funding:
6 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Apple Mobile Web Clips Icon Google Tag Manager Font Awesome Domain Not Resolving Apache Nginx
Similar Organizations
Salix Pharmaceuticals
Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2022-02-04 | Nimbus Health | Nimbus Health acquired by Dr. Reddy’s Laboratories | N/A |
| 2017-03-03 | Imperial Credit Pvt Ltd | Imperial Credit Pvt Ltd acquired by Dr. Reddy’s Laboratories | 20 M INR |
| 2006-03-03 | betapharm Arzneimittel GmbH | betapharm Arzneimittel GmbH acquired by Dr. Reddy’s Laboratories | 480 M EUR |
| 2004-05-07 | Trigenesis Therapeutics | Trigenesis Therapeutics acquired by Dr. Reddy’s Laboratories | 11 M USD |
| 2002-03-12 | BMS Laboratories Limited | BMS Laboratories Limited acquired by Dr. Reddy’s Laboratories | N/A |
| 1999-11-26 | American Remedies | American Remedies acquired by Dr. Reddy’s Laboratories | 90 M INR |
Investors List
MAPE Advisory Group
MAPE Advisory Group investment in Post-IPO Equity - Dr. Reddy’s Laboratories
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2005-09-30 | Perlecan Pharma | Dr. Reddy’s Laboratories investment in Series A - Perlecan Pharma | 52.5 M USD |
Official Site Inspections
http://www.drreddys.com Semrush global rank: 479.05 K Semrush visits lastest month: 106.15 K
- Host name: 98.111.98.34.bc.googleusercontent.com
- IP address: 34.98.111.98
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
